0001209191-18-001899.txt : 20180104
0001209191-18-001899.hdr.sgml : 20180104
20180104160711
ACCESSION NUMBER: 0001209191-18-001899
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180103
FILED AS OF DATE: 20180104
DATE AS OF CHANGE: 20180104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lippoldt Darin
CENTRAL INDEX KEY: 0001504783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 18510144
MAIL ADDRESS:
STREET 1: C/O VOLCANO CORPORATION
STREET 2: 3661 VALLEY CENTRE DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-03
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001504783
Lippoldt Darin
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Legal Officer
Common Stock
2018-01-03
4
M
0
1979
18.15
A
15136
D
Common Stock
2018-01-03
4
S
0
1979
79.36
D
13157
D
Non-Qualified Stock Option
18.15
2018-01-03
4
M
0
1979
18.15
D
2024-11-03
Common Stock
1979
19789
D
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Represents option which vests 1/4 upon anniversary of grant (11/3/2014), thereafter vesting in equal monthly installments over the following three years such that the entire award is fully vested at 11/3/2018.
/s/ Darin Lippoldt
2018-01-04